Título

Anti-inflammatory drugs and uterine cervical cancer cells: antineoplastic effect of meclofenamic acid

Autor

ALEJANDRO DAVID SORIANO HERNANDEZ

DANIELA MADRIGAL PÉREZ

HECTOR RAFAEL GALVAN SALAZAR

MARGARITA DE LA LUZ MARTINEZ FIERRO

LAURA LETICIA VALDEZ VELAZQUEZ

FRANCISCO ESPINOZA GOMEZ

OSCAR FERNANDO VAZQUEZ VUELVAS

BERTHA ALICIA OLMEDO BUENROSTRO

JOSE GUZMAN ESQUIVEL

IRAM PABLO RODRIGUEZ SANCHEZ

AGUSTIN LARA ESQUEDA

DANIEL ALBERTO MONTES GALINDO

IVAN DELGADO ENCISO

Nivel de Acceso

Acceso Abierto

Licencia

http://creativecommons.org/licenses/by/4.0

Materias

MEDICINA Y CIENCIAS DE LA SALUD - (CTI) Non-steroidal anti-inflamatory drugs - (SIN FUENTE) Meclofenamic Acid - (SIN FUENTE) Antitumor activity - (SIN FUENTE) Uterine cervical cancer - (SIN FUENTE) Murine model - (SIN FUENTE)

Resumen o descripción

Uterine cervical cancer (UCC) is one of the main causes of cancer-associated mortality in women. Inflammation has been identified as an important component of this neoplasia; in this context, anti-inflammatory drugs represent possible prophylactic and/or therapeutic alternatives that require further investigation. Anti-inflammatory drugs are common and each one may exhibit a different antineoplastic effect. As a result, the present study investigated different anti-inflammatory models of UCC in vitro and in vivo. Celecoxib, sulindac, nimesulide, dexamethasone, meclofenamic acid, flufenamic acid and mefenamic acid were tested in UCC HeLa, VIPA, INBL and SiHa cell lines.

Editor

Spandidos Publications

Fecha de publicación

octubre de 2015

Tipo de publicación

Artículo

Recurso de información

http://biblos.ucol.mx//handle/123456789/249

Idioma

Inglés

Repositorio Orígen

Repositorio institucional de la Universidad de Colima

Descargas

0